Towards optimized breast cancer 3D spheroid mono- and co-culture models for pharmacological research and screening
Author:
Affiliation:
1. Institute of Molecular and Cellular Biology, Mannheim University of Applied Sciences, Mannheim, Germany
2. Institute of Medical Technology of Heidelberg University and Mannheim University of Applied Sciences, Mannheim, Germany
Publisher
IOS Press
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biotechnology
Reference55 articles.
1. Rbuilding Big Pharma’s Business Model: The blockbuster business model that underpinned Big Pharma’s success is now irreparably broken. The industry needs a new approach;Gilbert;In Vivo The Business & Medicine Report,2003
2. Estimation of clinical trial success rates and related parameters;Wong;Biostatistics,2019
3. Research and development spending to bring a single cancer drug to market and revenues after approval;Prasad;JAMA Intern Med,2017
4. Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro;Brinkley;Cancer Res,1980
5. Breast tumor cell lines from pleural effusions;Cailleau;J Natl Cancer Inst,1974
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A multiparametric analysis including single-cell and subcellular feature assessment reveals differential behavior of spheroid cultures on distinct ultra-low attachment plate types;Frontiers in Bioengineering and Biotechnology;2024-08-02
2. Modelling bone metastasis in spheroids to study cancer progression and screen cisplatin efficacy;Cell Proliferation;2024-06-20
3. A Multiparametric Analysis Reveals Differential Behavior of Spheroid Cultures on Distinct Ultra-Low Attachment Plates Types;2024-03-29
4. A 3D In Vitro Triculture Hybrid Model Recapitulating Tumor Stromal Interaction of Triple‐Negative Breast Cancer as a High Throughput Anticancer Drug Screening Platform;Advanced Therapeutics;2024-02-11
5. Decellularized plant-derived vasculature-on-a-chip interacting with breast cancer spheroids to evaluate a dual-drug therapy;Applied Materials Today;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3